Journal article
An australian audit of vaccination status in children and adolescents with inflammatory bowel disease
NW Crawford, AG Catto-Smith, MR Oliver, DJS Cameron, JP Buttery
BMC Gastroenterology | Published : 2011
Abstract
Background: Children and adolescents with inflammatory bowel disease (IBD) are at increased risk of vaccine preventable diseases (VPD). This includes invasive pneumococcal disease and influenza. The primary aim of this study was to describe compliance with current Australian guidelines for vaccination of children and adolescents diagnosed with IBD. A secondary aim was to review the serological screening for VPD.Methods: A random sample of patients (0-18 years at diagnosis), were selected from the Victoria Australia state based Pediatric Inflammatory Bowel Disease Register. A multi-faceted retrospective review of immunization status was , with hospital records audited, a telephone interview s..
View full abstractGrants
Awarded by National Health and Medical Research Council
Funding Acknowledgements
[ "Thanks to all the participants and their parents/guardians who took part in the study. Thanks also to all the staff that helped with recruitment, including Ms Di Simpson (Gastroenterology Department RCH), staff in outpatient clinics and Immunization research assistants who helped undertake the audit (Catherine Lloyd-Johnson, Susi Rogers, Nicole Davidson)", "Dr Nigel Crawford acknowledges support from a National Health and Medical Research Council (NHMRC) of Australia PhD Postgraduate Public Health Scholarship (437031)", "NWC has investigator-led study support for a study of Guillain-Barre Syndrome Surveillance post H1N1 influenza vaccination [CSL] and been on a Pfizer [Wyeth] advisory board for pneumococcal vaccines and presented at conferences, for which his MCRI research fund has received honoraria. AGC has chaired an advisory board for GSK - rotavirus vaccine and chaired an advisory board for MSD - Infliximab in Crohn's disease. JPB sits on a data safety monitoring board for influenza vaccines [CSL] and MCRI has received conference travel reimbursement from GSK for Rotavirus vaccine conference presentation. MRO and DJSC have no conflicts of interests to declare." ]